Ventas Inc
For the period ended May 13, 2025. Filed Apr 1, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 13, 2025 · Filed Apr 1, 2025
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No. )
| þ | Filed by the Registrant | o | Filed by a party other than the Registrant |
|---|
| CHECK THE APPROPRIATE BOX: | |
|---|---|
| o | Preliminary Proxy Statement |
| o | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| þ | Definitive Proxy Statement |
| o | Definitive Additional Materials |
| o | Soliciting Material under §240.14a-12 |
Ventas, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
| PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY): | |
|---|---|
| þ | No fee required |
| o | Fee paid previously with preliminary materials |
| o | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
Letter to Ventas Stockholders
Dear Fellow Stockholder,
On behalf of our Board of Directors, I am pleased to present the 2025 Ventas Proxy Statement and invite you to join our Annual Meeting of Stockholders on May 13, 2025. Ventas delivered outstanding operating results and returns for stockholders in 2024 as we executed on our focused strategy to capture the unprecedented multiyear growth opportunity in senior housing.We delivered a total shareholder return of more than 22%,* outperforming the FTSE Nareit Health Care Index and the MSCI U.S. REIT Index for the third consecutive year and extending our track record of strong returns and outperformance for the near-, intermediate- and long-term.** Total annualized returns to shareholders since January 1, 2000 have exceeded 18%, demonstrating the power of our position, advantaged platform and talented team.** An Essential Participant in Longevity EconomyOur nearly 1,400 assets are unified in serving the large and growing aging population, positioning Ventas as a leading participant in the longevity economy. With the first of more than 70 million baby boomers reaching the age of 80 next year, the U.S. 80+ population is anticipated to grow from about 14 million to about 18 million over the next five years—an increase of 28%.(1)This surge in the senior population has created strong demand for Ventas’s senior housing communities where, today, approximately 85,000 residents are enjoying the proven health, well-being and longevity benefits of living in a supported, affordable community environment. Yet, as hundreds of thousands more Americans are turning 80 each year, construction starts in senior housing have fallen to historic lows.(2) We expect this imbalance between demand and supply to provide a long runway for Ventas to grow.Executing Our Focused StrategyAgainst this backdrop of projected compelling secular demand, we are executing on our focused 1-2-3 strategy to drive growth and create value. In 2024, our team delivered the third consecutive year of double-digit growth in our senior housing operating portfolio ("SHOP") and leveraged our unique competitive advantages to complete over $2 billion of accretive investments that enhance our growth profile.These investments, which were focused on senior housing, met our well-defined operational and financial criteria, and were consistent with our Right Market, Right Asset, Right OperatorTM approach. Compounding contributions from our outpatient medical buildings, research centers and healthcare properties complemented our strong results in SHOP.
(1)Oxford Economics, as of December 2024
(2)National Investment Center for Seniors Housing & Care, as of 4Q24
- FactSet, for the periods ending December 31, 2024
** Alexandria Real Estate Equities, Inc. (NYSE: ARE) was added to the Nareit Health Care Index in June 2024 on a prospective basis. Nareit Health Care Index returns reflect ARE performance for the entire 1- and 3-year periods and are as reported for all other periods.
| 2025 | Proxy Statement | i |
|---|
Letter to Ventas Stockholders
We believe financial strength and flexibility are imperative to our growth and performance. In 2024, we raised $4 billion in attractive capital, significantly improved our leverage, grew our scale and enhanced our strong financial position to support future growth. Building on our results and positive outlook, we recently announced a 7% increase in our quarterly dividend. We are focused on creating value from our advantaged position within the longevity economy as we enable exceptional environments that benefit a large and growing aging population.Benefiting from Strong, Independent Board of DirectorsAs we execute on this mission, Ventas continues to benefit from a strong, independent and deeply engaged Board of Directors, with the right mix of experience, skills and judgment. I encourage you to read about our directors, our rigorous corporate governance standards and risk-management practices, “pay-for-performance” approach to executive compensation and other important topics in this proxy statement.We are excited to continue building value for our stockholders and appreciate your investment in our Company. We remain committed to rewarding your trust with results and performance.
Sincerely, Debra A. CafaroChairman and Chief Executive Officer
| ii | 2025 | Proxy Statement |
|---|
Notice of 2025 Annual Meeting of Stockholders
| Date & Time | Location | Record Date | Outstanding Shares |
|---|---|---|---|
| Tuesday, May 13, 20258:00 a.m. Central Time | The 2025 Annual Meeting will be conducted as a virtual meeting at www.virtualshareholdermeeting.com/VTR2025. There is no physical location for the 2025 Annual Meeting. | March 19, 2025 | On the record date, there were approximately 437,697,802 shares of common stock issued and outstanding and entitled to vote at the meeting. |
| Agenda | Board Recommendation | |
| 1 | To elect the 12 director nominees named in this Proxy Statement to serve until the 2026 Annual Meeting of Stockholders | FOR each director nominee |
| 2 | To approve, on an advisory basis, the compensation of our Named Executive Officers | FOR |
| 3 | To ratify the selection of KPMG LLP as our independent registered public accounting firm for the 2025 fiscal year | FOR |
| 4 | To approve an amendment to the Amended and Restated Certificate of Incorporation of Ventas, Inc. to increase the number of authorized shares of common stock | FOR |
| 5 | To approve an amendment to the Amended and Restated Certificate of Incorporation of Ventas, Inc. to limit the liability of certain officers as permitted by Delaware Law | FOR |
To transact such other business as may properly come before the meeting or any adjournment or postponements thereof.
Casting Your Vote
Your vote is very important. Please carefully review the proxy materials for the 2025 Annual Meeting of Stockholders and follow the instructions below to cast your vote promptly on all voting matters.
| By TelephoneCall the number shown on the enclosed proxy card. | By MailRequest, complete and return the proxy card in the postage-paid envelope provided. |
| Via the InternetVisit the website shown on the enclosed proxy card. | During the MeetingAttend the virtual meeting via live webcast at www.virtualshareholdermeeting.com/VTR2025 and vote by ballot online. |
We urge you to vote by proxy as soon as possible to ensure that your shares are represented at the 2025 Annual Meeting whether or not you currently plan to attend. You do not need to attend the meeting to vote if you vote your shares before the meeting.
PLEASE NOTE: We encourage all stockholders to vote electronically – by Internet or telephone – whenever possible.
| 2025 | Proxy Statement | iii |
|---|
Notice of 2025 Annual Meeting of Stockholders
Participating in the Meeting
Attendance at the 2025 Annual Meeting or any adjournment or postponement thereof will be limited to stockholders of the Company as of the close of business on March 19, 2025, the record date, and guests of the Company. The meeting will be held virtually at www.virtualshareholdermeeting.com/VTR2025. You will not be able to attend the 2025 Annual Meeting in person at a physical location. To attend and participate in the meeting, stockholders will need the 16-digit control number included in the Notice of Meeting, on their proxy card or on the voting instruction form or other instructions.
Stockholders as of the close of business on the record date who attend and participate in the 2025 Annual Meeting will have an opportunity to submit questions live via the Internet during the 2025 Annual Meeting. Please review “Information About Our 2025 Annual Meeting” beginning on page 97 of this Proxy Statement for information about attending and voting at the 2025 Annual Meeting.
| By Order of the Board of Directors,Carey S. Roberts Executive Vice President, General Counsel and Ethics & Compliance Officer April 1, 2025Chicago, Illinois | Important Notice Regarding Internet Availability of Proxy Materials for May 13, 2025, Annual MeetingWe are sending this Proxy Statement and making this Proxy Statement first available on or about April 1, 2025. This Proxy Statement and our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 are available via the internet at www.proxyvote.com. |
|---|
| iv | 2025 | Proxy Statement |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.